STUDresearch · Non-peptide

Alpha-Ketoglutarate (AKG)

Also known as

Ca-AKG · calcium alpha-ketoglutarate

Community talk. May be wrong. Not medical advice. Not a protocol. Not for human or animal use.

Open in the directory ↗
Non-peptide Some talk Systemic Oral Longevity / cellular

Systemic metabolic intermediate supplement.

Tap a line to jump into the full notes. Research only — may be wrong.

Timing context & sources

Half-life in the body

A human oral Ca-AKG half-life is not established by the checked evidence.

The under-five-minute figure is for pig portal-vein administration. Human oral radiotracer work studied absorption of 5–20 g antidote formulations, not routine supplement clearance.

No animal-to-human or tracer-to-parent conversion; endogenous metabolism, formulation and exposure route remain distinct.

  • Dąbek et al. — pig AKG absorption and kinetics (opens in a new tab)Original abstract via Europe PMC core API: pigs studied by IV, portal-vein, oral, duodenal and ileal administration; under-five-minute blood half-life belongs specifically to portal-vein AKG.Pig portal-vein exposure, not human oral Ca-AKG, free-acid supplement or sustained-release PK. Other administration routes were studied but this reported half-life must not be assigned to all of them.
  • Mittal et al. — oral AKG radiotracer study (opens in a new tab)Original abstract via Europe PMC core API, Methods/Results: technetium-99m-labeled AKG, human oral 5–20 g single/split amounts and water-dependent absorption; animal cohorts separately described.An antidote-formulation absorption study, not ordinary 1–2 g/day Ca-AKG supplement PK. Radiotracer bioavailability is not a measured parent-AKG elimination half-life or a dosing instruction.

Felt duration people report

Some describe early subtle changes; others notice nothing over months or years.

Actual follow-ups include continuing benefit within a stack and an initially positive Ca-AKG account that stopped because of intolerance. No common single-dose duration emerges.

Self-report, different preparations and co-use; perceived changes after stopping do not measure clearance or prove dependence.

  • AKG experiences — benefits, nulls and later replies (opens in a new tab)Actual thread and visible follow-ups: Biohorology August 30, 2023 exercise benefit and April 17, 2026 continued use within a stack; vauss88 years of no observable effect; 1,000 mg/day four-month null account; January 17, 2026 one-week energy/stomach report.Different AKG forms, branded mixtures and stacks; not pooled efficacy or a standard onset. Commenters' five-minute human claims, salt-superiority claims and biological-age extrapolations are not adopted.
  • Ca-AKG report — initial benefits and intolerance follow-up (opens in a new tab)Actual magenk account: January 9, 2025 OP after roughly a month; brand-change replies; March 7 update reports stomach/bladder irritation even without piperine or with liposomal forms, stopping and perceived mood/appearance changes over 1–2 weeks.Long COVID, prednisone and changing products confound attribution. Subjective post-stop timing does not measure clearance or establish dependence. No new formulation is recommended.

What people say 5

  • Training recovery talk: Human evidence mixed. forum
  • Healthspan narrative: Alpha-Ketoglutarate (AKG) is discussed for aging markers, energy, or recovery more than acute gym pumps. forum
  • Slow endpoints: Users often run months, not days, before claiming anything — and still confabulate. anecdote
  • Stack noise: Frequently combined with multi-agent longevity stacks that destroy attribution. forum
  • Longevity mouse lore: AKG lifespan/healthspan narratives in animals. animal

Doses people talk about 6

  • Quality flag: Assume label accuracy only if analytically verified — gray market fill error is common. forum
  • Product quality: Gray-market fill accuracy and identity are uncertain; dose math assumes the label is true. forum
  • Route changes the math: Oral vs SC vs nasal are not interchangeable milligram-for-milligram stories. forum
  • Gram oral bands: Commonly discussed 1–2+ g/day calcium-AKG-style products. This describes product or salt mass as labeled, not 1–2+ g of elemental calcium or a guaranteed equivalent amount of free AKG. forum
  • Start conservative (community): When people experiment, they often start at the low end of a charted band to gauge tolerance — still not advice. forum
  • Framing: All figures are discussed trial, clinic, or community amounts — research/educational only, not prescriptions. forum

How it may feel 5

  • Days 1–7: Oral GI/mood changes are discussed. The original conditional site-reaction note concerns injection, not the ordinary oral supplement route, and does not establish an AKG injection practice or an onset window. forum
  • Months: Supplement discussions span months or ongoing use. Actual accounts range from subtle exercise benefits with continued stacked use to no observable effect over months or years. A Ca-AKG poster later stopped for stomach/bladder irritation despite perceived benefits. forum
  • Day 1: Oral route and GI tolerability are more practical talking points than a “miracle” effect from AKG; the generic sting comparison applies only if injected, not to usual capsules, tablets or powder. forum
  • Days 2–7: Side-effect window for many agents; benefits, if any, are easy to mis-attribute. forum
  • Weeks 1–2: First honest checkpoint in self-logs. forum

Cycles people discuss 4

  • Daily ongoing: Some community accounts describe daily oral supplementation for months or years; others stop for no benefit or intolerance. This is a use pattern, not a validated on/off schedule. forum
  • Other patterns: Weeks-on / weeks-off self-protocols also appear in broader discussion, with cost and caution as rationales rather than hard science. They are not a universal AKG pattern and coexist with the daily ongoing accounts above. forum
  • No magic cycle: There is rarely one universal “correct” on/off calendar across forums. forum
  • Reassess: Stop and reassess if adverse effects appear; this is not medical care. forum

Timing 3

  • Timing practicalities: People time doses around side effects, training, and sleep more than perfect PK. forum
  • Metabolite turnover: The often-quoted blood half-life under five minutes comes from AKG delivered into the portal vein of pigs. It is not a human oral Ca-AKG half-life; a formulation-specific human parent estimate is not established by the sources checked here. animal
  • Published PK: Human oral AKG radiotracer work used 5–20 g in an antidote-formulation absorption study. It does not establish an elimination half-life for ordinary Ca-AKG supplements, and tracer absorption is not intact-parent residence. trial

More on what it is 5

  • What it is: Alpha-ketoglutarate (often Ca-AKG) TCA-cycle metabolite sold for longevity/training. Free-acid AKG, calcium-AKG (Ca-AKG), arginine-AKG and ornithine-AKG are different preparations; supplement mass is not interchangeable with elemental calcium or free-AKG mass. forum
  • See also: Ca-AKG already cataloged under related calcium salt marketing. forum
  • Research posture: Educational summary of public discussion and literature themes only. forum
  • How people talk about it: Forum volume is a popularity signal for Alpha-Ketoglutarate (AKG), not proof it works for you. forum
  • Research only: Not approved advice for self-experimentation; legality and access vary by place. forum

Stacks 2

  • With NMN/resveratrol marketing stacks: AKG is discussed alongside NMN and resveratrol in longevity stacks; combined use makes individual effects difficult to attribute. forum
  • Less is clearer: Solo runs make personal n=1 easier to interpret than five-compound blasts. forum

Storage notes 2

  • No mix instructions here: STUDresearch does not list reconstitution, diluent volumes, or syringe unit charts. People reconstitute many different ways and vial labels differ — that content creates more confusion than clarity. forum
  • Storage (general talk only): Unopened research products are usually kept cool, dry, and away from light per the seller label. Anything after first use is product-specific — follow the label, not a universal forum SOP. forum

Watch for 6

  • GI: Possible at high doses, and lower-dose or product-specific intolerance is also reported. One Ca-AKG poster stopped after stomach/bladder irritation across several preparations despite perceived benefits; this is an individual account, not a known response rate. forum
  • General caution: Research chemical and compounded sources vary; adverse events may be under-reported. forum
  • Injection site (if injected): Redness, itch, lumps, bruise — technique and product quality matter. forum
  • Unknowns: Long-term safety for gray-market preparations is often poorly characterized. forum
  • Stack noise: Sides logged on multi-agent stacks cannot be blamed cleanly on one compound. forum
  • Seek care red flags: Severe allergic reaction, chest pain, neuro changes, or uncontrolled BP/glucose need real medical care — not forum advice. forum

Updated: 2026-08-12

Evidence mix Mostly community / anecdote tags Full: every bullet (trial + community). Use Scan for a faster bro-science read.

All STUDresearch topics →